Triolein emulsion enhances temozolomide brain delivery: an experimental study in rats

References

• Abbott NJ. (2013). Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437–49.
   PubMed Web of Science ®Google Scholar
• Agar NY, Golby AJ, Ligon KL, et al. (2011). Development of stereotactic mass spectrometry for brain tumor surgery. Neurosurgery 68:280–9; discussion 90.
   PubMed Web of Science ®Google Scholar
• Agarwala SS, Kirkwood JM. (2000). Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 5:144–51.
   PubMedGoogle Scholar
• Baik SK, Kim YW, Kim HJ, et al. (2008). Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats. Acta Radiol 49:1174–81.
   PubMed Web of Science ®Google Scholar
• Beier D, Schulz JB, Beier CP. (2011). Chemoresistance of glioblastoma cancer stem cells-much more complex than expected. Mol Cancer 10:128.
   PubMed Web of Science ®Google Scholar
• Brada M, Judson I, Beale P, et al. (1999). Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies. Br J Cancer 81:1022–30.
   PubMed Web of Science ®Google Scholar
• Calligaris D, Caragacianu D, Liu X, et al. (2014). Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis. Proc Natl Acad Sci USA 111:15184–9.
   PubMed Web of Science ®Google Scholar
• Catuogno S, Esposito CL, Quintavalle C, et al. (2012). Nucleic acids in human glioma treatment: innovative approaches and recent results. J Signal Transduct 2012:735135.
   PubMedGoogle Scholar
• Chamberlain MC. (2010). Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert Rev Neurother 10:1537–44.
   PubMed Web of Science ®Google Scholar
• Cooks RG, Ouyang Z, Takats Z, Wiseman JM. (2006). Detection technologies. Ambient mass spectrometry. Science 311:1566–70.
   PubMed Web of Science ®Google Scholar
• Cruceru ML, Neagu M, Demoulin JB, Constantinescu SN. (2013). Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. J Cell Mol Med 17:1218–35.
   PubMed Web of Science ®Google Scholar
• Denny BJ, Wheelhouse RT, Stevens MF, et al. (1994). NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA. Biochemistry 33:9045–51.
   PubMed Web of Science ®Google Scholar
• Diez BD, Statkevich P, Zhu Y, et al. (2010). Evaluation of the exposure equivalence of oral versus intravenous temozolomide. Cancer Chemother Pharmacol 65:727–34.
   PubMed Web of Science ®Google Scholar
• Eberlin LS, Ferreira CR, Dill AL, et al. (2011). Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging. Biochim Biophys Acta 1811:946–60.
   PubMed Web of Science ®Google Scholar
• Estlin EJ, Lashford L, Ablett S, et al. (1998). Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer 78:652–61.
   PubMed Web of Science ®Google Scholar
• Gibson NW, Hickman JA, Erickson LC. (1984). DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one. Cancer Res 44:1772–5.
   PubMed Web of Science ®Google Scholar
• Gilant E, Kaza M, Szlagowska A, et al. (2012). Validated HPLC method for determination of temozolomide in human plasma. Acta Pol Pharm 69:1347–55.
   PubMed Web of Science ®Google Scholar
• Jackson S, Anders NM, Mangraviti A, et al. (2016). The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain. J Neurooncol 126:433–9.
   PubMed Web of Science ®Google Scholar
• Kerian KS, Jarmusch AK, Pirro V, et al. (2015). Differentiation of prostate cancer from normal tissue in radical prostatectomy specimens by desorption electrospray ionization and touch spray ionization mass spectrometry. Analyst 140:1090–8.
   PubMed Web of Science ®Google Scholar
• Kim H, Likhari P, Parker D, et al. (2001). High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma. Pharm Biomed Anal 24:461–8.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim YW, Choi SH, et al. (2016). Triolein emulsion infusion into the carotid artery increases brain permeability to anticancer agents. Neurosurgery 78:726–32.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim YW, Lee IS, et al. (2009). Intra-arterial delivery of triolein emulsion increases vascular permeability in skeletal muscles of rabbits. Acta Vet Scand 51:30.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee CH, Kim HG, et al. (2004). Reversible MR changes in the cat brain after cerebral fat embolism induced by triolein emulsion. AJNR Am J Neuroradiol 25:958–63.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee CH, Lee SH, et al. (2001). Early development of vasogenic edema in experimental cerebral fat embolism in cats: correlation with MRI and electron microscopic findings. Invest Radiol 36:460–9.
   PubMed Web of Science ®Google Scholar
• Kim KN, Kim HJ, Lee SD, et al. (2004). Effect of triolein emulsion on the blood-testis barrier in cats. Invest Radiol 39:445–9.
   PubMed Web of Science ®Google Scholar
• Kim Y-W, Kim HJ, Cho BM, Choi SH. (2021). Triolein emulsion infusion into the hepatic artery increases vascular permeability to doxorubicin in rabbit liver. World J Gastroenterol 27:152–61.
   PubMed Web of Science ®Google Scholar
• Kim YW, Kim HJ, Cho BM, et al. (2006). The study of cerebral hemodynamics in the hyperacute stage of fat embolism induced by triolein emulsion. AJNR Am J Neuroradiol 27:398–401.
   PubMed Web of Science ®Google Scholar
• Lee JE, Jea SY, Oum BS, et al. (2009). Effect of fat embolism with triolein emulsion on blood-retinal barrier. Ophthalmic Res 41:14–20.
   PubMed Web of Science ®Google Scholar
• Liu HL, Huang CY, Chen JY, et al. (2014). Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment. PLoS One 9:e114311.
   PubMed Web of Science ®Google Scholar
• Lostun D, Perez CJ, Licence P, et al. (2015). Reactive DESI-MS imaging of biological tissues with dicationic ion-pairing compounds. Anal Chem 87:3286–93.
   PubMed Web of Science ®Google Scholar
• Marchesi F, Turriziani M, Tortorelli G, et al. (2007). Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol Res 56:275–87.
   PubMed Web of Science ®Google Scholar
• Meany HJ, Warren KE, Fox E, et al. (2009). Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors. Cancer Chemother Pharmacol 65:137–42.
   PubMed Web of Science ®Google Scholar
• Ostermann S, Csajka C, Buclin T, et al. (2004). Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10:3728–36.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2007). Blood-brain barrier delivery. Drug Discov Today 12:54–61.
   PubMed Web of Science ®Google Scholar
• Patel M, McCully C, Godwin K, Balis FM. (2003). Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. J Neuro-Oncol 61:203–7.
   PubMed Web of Science ®Google Scholar
• Reyderman L, Statkevich P, Thonoor CM, et al. (2004). Disposition and pharmacokinetics of temozolomide in rat. Xenobiotica 34:487–500.
   PubMed Web of Science ®Google Scholar
• Ruggiero A, Cefalo G, Garre ML, et al. (2006). Phase II trial of temozolomide in children with recurrent high-grade glioma. J Neurooncol 77:89–94.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Jeong YJ, Kim HJ, Kim DH, et al. (2010). MRI of the cat brain in the study of vascular permeability after intraarterial carotid injection of triolein. Acta Radiol 51:563–8.
   PubMed Web of Science ®Google Scholar
• Santagata S, Eberlin LS, Norton I, et al. (2014). Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proc Natl Acad Sci USA 111:11121–6.
   PubMed Web of Science ®Google Scholar
• Sol Y, Choi SH, Kim HJ, et al. (2017). Morphologic mechanisms of increased vascular permeability of triolein emulsion to the blood-brain barrier. Microscopy 66:366–70.
   PubMed Web of Science ®Google Scholar
• Stevens MF, Hickman JA, Stone R, et al. (1984). Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one, a novel broad-spectrum antitumor agent . J Med Chem 27:196–201.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–96.
   PubMed Web of Science ®Google Scholar
• Takats Z, Wiseman JM, Gologan B, Cooks RG. (2004). Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306:471–3.
   PubMed Web of Science ®Google Scholar
• Tentori L, Graziani G. (2009). Recent approaches to improve the antitumor efficacy of temozolomide. Curr Med Chem 16:245–57.
   PubMed Web of Science ®Google Scholar
• Veringa SJ, Biesmans D, van Vuurden DG, et al. (2013). In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma. PLoS One 8:e61512.
   PubMed Web of Science ®Google Scholar
• Wiseman JM, Puolitaival SM, Takats Z, et al. (2005). Mass spectrometric profiling of intact biological tissue by using desorption electrospray ionization. Angew Chem Int Ed Engl 44:7094–7.
   PubMed Web of Science ®Google Scholar
• Zhan C, Lu W. (2012). The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery. Curr Pharm Biotechnol 13:2380–7.
   PubMed Web of Science ®Google Scholar
• Zhang J, Stevens MF, Bradshaw TD. (2012). Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 5:102–14.
   PubMedGoogle Scholar